Skip to main content
DNA Labs India

Lung Cancer Awareness Month 2025: Genetic Screening and Early Detection

Genomic & Hereditary Oncology | DNA Labs India

Genomic & Hereditary Oncology

Lung Cancer Awareness Month 2025: Genetic Screening and Early Detection

Learn about lung cancer awareness, genetic testing, and early detection. Discover Liquid Biopsy and OncoPRO panels at DNA Labs India.

Lung Cancer Awareness Month 2025: Genetic Screening and Early Detection
Lung Cancer Awareness Month 2025: Genetic Screening and Early Detection
Medical GeneticistGenomic & Hereditary Oncology
Written by: Lookesh SharmaMedically Reviewed by: Dr Sulochana Hemchandra Holla, MBBS, MD (Medical Genetics)Last Updated: September 09, 2026

Key Facts at a Glance

  • Sample Required: Blood or tissue biopsy (for Liquid Biopsy: blood sample; for OncoPRO: blood or saliva)
  • Fasting Rules: Not required
  • Turnaround Time (TAT): 7–10 working days
  • Base Cost: [Insert Current 2026 Price]

Written by: Dr. Ananya Sharma, PhD, Medical Geneticist

Medically Reviewed by: Dr. Rajesh Kumar, MD, Pulmonologist

Last Updated: November 2025

Understanding Lung Cancer

Lung cancer occurs when abnormal cells in the lungs grow uncontrollably, forming tumors that interfere with breathing and oxygen exchange. It is one of the leading causes of cancer-related mortality worldwide, but early detection significantly improves survival rates.

There are two primary types:

  • Non-Small Cell Lung Cancer (NSCLC): The most common form, accounting for about 85% of cases.
  • Small Cell Lung Cancer (SCLC): A more aggressive, rapidly spreading type.

While smoking is a major risk factor, 20–25% of lung cancer cases occur in non-smokers, often due to genetic mutations, air pollution, or exposure to carcinogens.

Risk Factors and Genetic Predisposition

Understanding what increases your risk can help in making preventive health choices:

  • Tobacco use or exposure to secondhand smoke
  • Radon gas (a naturally occurring radioactive gas found in homes)
  • Air pollution and industrial toxins
  • Occupational exposure to chemicals like asbestos or arsenic
  • Genetic predisposition or a family history of lung cancer

If you have any of these risk factors, speak with your doctor about genetic screening or diagnostic testing.

Early Detection and Screening Modalities

One of the greatest challenges in treating lung cancer is that symptoms often appear only in the later stages. Early-stage lung cancer, when detected through screening or genetic testing, is much more treatable.

Key Screening Options:

  • Low-Dose CT (LDCT) Scans for high-risk individuals (ages 50–80 with a history of smoking or chemical exposure).
  • Genetic Testing to identify inherited mutations that increase lung cancer risk.

DNA Labs India offers advanced genetic and molecular diagnostic tests that can detect mutations linked to lung cancer susceptibility, helping patients take proactive steps toward prevention and early intervention.

Genetic Testing for Hereditary Lung Cancer Risk

Our laboratory utilizes Next-Generation Sequencing (NGS) and Whole Exome Sequencing (WES) to analyze genes associated with hereditary cancer syndromes. These advanced technologies provide comprehensive insights into your genetic predisposition, enabling personalized prevention and surveillance strategies.

We offer two primary tests:

Test Comparison: Liquid Biopsy vs. OncoPRO Panel

FeatureLiquid BiopsyOncoPRO Panel
Sample TypeBloodBlood or Saliva
PurposeDetection of tumor DNA (ctDNA) for early diagnosis and monitoringIdentification of inherited mutations increasing cancer risk
Turnaround Time7–10 working days10–14 working days
Cost[Insert Current 2026 Price][Insert Current 2026 Price]

How to Support Lung Cancer Awareness Month

Everyone can contribute to spreading awareness and saving lives:

  • Wear a white or pearl ribbon in solidarity.
  • Share educational posts using #LungCancerAwarenessMonth and #ShineALight.
  • Encourage family and friends to get screened.
  • Support or donate to cancer research and patient care organizations.

Your voice can help break stigma, promote awareness, and drive early testing.

Conclusion and Next Steps

Lung Cancer Awareness Month 2025 serves as a powerful reminder that awareness, screening, and genetic insight can make a real difference.

By identifying risks early and embracing preventive healthcare, we can reduce mortality and improve outcomes for patients across India.

This November, join DNA Labs India in shining a light on lung cancer awareness — because early detection saves lives.

Know your risk today.
Schedule a Liquid Biopsy Lung Cancer Test or OncoPRO Hereditary Cancer Risk Panel Test, or speak to our experts about Lung Cancer Genetic Screening at www.dnalabsindia.com

💡 Key Takeaways

  • This article was written by Lookesh Sharma.
  • Last updated on September 9, 2026. Clinical information is reviewed periodically.
  • Always consult with a qualified healthcare provider before making medical decisions based on the information presented here.

Need Personalized Clinical Guidance?

The information in this article is intended for educational purposes and reflects current scientific understanding. To understand how these insights apply to your specific health profile or family history, speak with a certified genetic counselor at DNA Labs India.

Medical Disclaimer: The clinical insights provided here are intended for educational purposes and do not replace professional medical advice from a primary physician. DNA Labs India is an ISO 9001:2015 certified diagnostic laboratory. Always consult with a qualified healthcare provider regarding any medical concerns, diagnoses, or treatment decisions.

Related Articles in Genomic & Hereditary Oncology

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.